Worldwide, the magnitude of PID-related morbidity is still enormous. The proportion of tubal factor infertility of all infertility ranges from 37 % in developed countries to 85% in developing countries. 6 Our understanding of the pathogenesis of PID and PID-related sequelae has increased along with a better understanding of the immunopathogenesis of CT infection. Early studies had already suggested that a single acute infection per se could not account for all the pathology associated with chlamydial disease. 7 The persistence of chronic inflammation after proper therapy for chlamydial infection has been a puzzling phenomenon in many clinical studies. For instance, persistent cervicitis not explained by relapse or reinfection was found 3 months after therapy in 23-33% of women treated for chlamydial mucopurulent cervicitis. Similarly, not only adhesion formation and tubal occlusions but also persistent inflammation of the fallopian tubes in the absence of CT were frequently seen during a second-look laparoscopy performed 4-6 months after the index episode.
The main sources of a repeat or prolonged antigenic stimulus leading to systemic sensitization against chlamydiae are the persistence of subclinical infection after unsatisfactory treatment and recurrent infection. Subclinical PID (plasma-cell endometritis) has been detected in two-thirds of women with chlamydial mucopurulent cervicitis. 2' 10 Poor compliance with antibiotic therapy is a major problem, increasing the risk of persistent infection. 11 In a survey of general practitioners in Norway, 63 different regimens were used for the treatment of PID. Only 46% of these regimens were compatible with standard treatment guidelines. 12 Similarly, recurrent infections are extremely common, particularly among adolescents. 13, 14 CT is a strong immunogen that stimulates both humoral and cell-mediated immune responses. 15 This organism can induce perturbations in immune function that may assist its survival in an infected host. 16 The ability of 31 A correlation of antibodies to HSP60 with microimmunofluorescence antibodies (toward chlamydial major outer-membrane protein antigen) has been detected in some, 31'33 but not all studies.
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The cell-mediated immune response to chlamydial HSPs has been less well studied, although it undoubtedly plays a critical role in the DHS response. The role of DHS in the pathogenesis of chlamydial salpingitis has been studied in the monkey "pocket" model. 34 Pigtailed monkeys were sensitized by inoculation of live CT organisms into subcutaneous pockets containing salpingeal autotransplants. When recombinant chlamydial HSP60 (rHSP60) was injected into pockets either previously sensitized or not sensitized in the same monkey, a typical DHS reaction was observed. Furthermore, a positive lymphocyte-proliferation response of peripheral-blood mononuclear cells to rI-ISP60 was more common in women with PID than in women without PID or in controls. 35 Interestingly, most of those with positive responses had histories of PID or ectopic pregnancy, suggesting that the duration of exposure is an important variable of the CT-specific T-cell 
